| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $64.4M | -33.5% |
| SG&A Expense | $28.4M | -5.5% |
| Operating Income | -$92.8M | +26.8% |
| Income Tax | $0 | — |
| Net Income | -$91.2M | +27.4% |
| EPS (Basic) | -$2.52 | +27.4% |
| EPS (Diluted) | -$2.52 | +27.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.3M | -47.8% |
| Current Assets | $127.7M | -40.8% |
| Total Assets | $156.3M | -36.9% |
| Current Liabilities | $15.3M | -35.4% |
| Total Liabilities | $40.6M | -21.7% |
| Stockholders' Equity | $115.7M | -40.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.1M | +15.0% |
| Capital Expenditures | $192K | -92.9% |
| Investing Cash Flow | $53.4M | -59.1% |
| Financing Cash Flow | $177K | -75.7% |
| Free Cash Flow | -$85.3M | +17.1% |